Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.720
-0.018 (-2.38%)
At close: Mar 6, 2026, 4:00 PM EST
0.720
-0.000 (-0.04%)
After-hours: Mar 6, 2026, 5:08 PM EST
Skye Bioscience Employees
Skye Bioscience had 16 employees as of December 31, 2024. The number of employees increased by 5 or 45.45% compared to the previous year.
Employees
16
Change (1Y)
5
Growth (1Y)
45.45%
Revenue / Employee
n/a
Profits / Employee
-$3,201,833
Market Cap
23.09M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| IO Biotech | 78 |
| Boundless Bio | 64 |
| Vistagen Therapeutics | 59 |
| Senti Biosciences | 34 |
| Daré Bioscience | 23 |
| FibroBiologics | 15 |
| Exicure | 8 |
SKYE News
- 1 day ago - Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026 - GlobeNewsWire
- 4 weeks ago - Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year - Benzinga
- 4 weeks ago - Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide - GlobeNewsWire
- 5 weeks ago - Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference - GlobeNewsWire
- 6 weeks ago - Skye Bioscience to Present Poster at Keystone Obesity Conference - GlobeNewsWire
- 7 weeks ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Newsfile Corp
- 7 weeks ago - INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - GlobeNewsWire
- 7 weeks ago - UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Newsfile Corp